Abstract:In elderly patients, morning blood pressure (BP) variability and surges are more insidious and pronounced than in younger adults due to their common arteriosclerosis, impaired baroreflex sensitivity, and multiple comorbidities. Routine office BP measurement often misses these critical abnormalities, making morning hypertension an independent risk factor for the high incidence of cardiovascular and cerebrovascular events and for cognitive decline in older adults. Based on 24-hour ambulatory blood pressure monitoring (ABPM), this article systematically describes the pathophysiological characteristics of morning hypertension in the elderly and proposes a precise classification based on our clinical experience. According to the dipping rate of nocturnal BP and the velocity of morning BP surge, morning hypertension in older adults is categorized into “nocturnal type” “morning surge type” and “mixed type”. In management strategies, we advocate treatment decisions based on cardiovascular risk stratification and individualized medication guided by ABPM results. Long-acting, stable antihypertensive agents should be prioritized, supplemented with chronotherapy and “peak-reduction” strategies. The article further addresses the pivotal role of frailty assessment in setting BP targets, controversies and cautious application of chronotherapy, and the value of novel drugs (ARNI/SGLT2 inhibitors) in elderly patients with multiple target-organ damage. By comprehensively discussing the central role of ABPM in the precise management of elderly morning hypertension, this article aims to provide clinical reference for developing tailored antihypertensive strategies and reducing the risk of multi-organ damage in this population.